本页面由Tiger Trade Technology Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

72.58
+0.97001.35%
盘后72.580.00000.00%19:17 EDT
成交量:149.37万
成交额:1.08亿
市值:140.71亿
市盈率:-19.20
高:73.41
开:71.54
低:70.77
收:71.61
52周最高:84.94
52周最低:28.33
股本:1.94亿
流通股本:1.51亿
量比:0.90
换手率:0.99%
股息:- -
股息率:- -
每股收益(TTM):-3.7800
每股收益(LYR):-3.7850
净资产收益率:-1789.67%
总资产收益率:-33.83%
市净率:-6.74
市盈率(LYR):-19.18

数据加载中...

2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

重要事件披露

Form 8-K - Current report
2026/01/21

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities